Non-responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co-stimulation

Clin Exp Immunol. 2005 Apr;140(1):126-37. doi: 10.1111/j.1365-2249.2004.02749.x.

Abstract

The mechanisms causing non-responsiveness to hepatitis B surface antigen (HBsAg) vaccines in man remain elusive. The increased incidence of non-responsiveness in subjects with HLA-DR3(+) or -DR7(+) haplotypes suggests that immune response mechanisms governed by genes of the MHC are involved. Homozygotes for these two haplotypes are found almost exclusively in the non-responder (NR) population. It is conceivable that antigen-presenting cells (APC) of NR are defective in the uptake of HBsAg and that they are unable to present this Ag adequately. Previously, we demonstrated that DR2(+), DR7(+) and DP4(+) NR were able to present HBsAg. In the present paper we demonstrate that six DR0301(+) NR, five of which are homozygous for this marker, were able to take up, process and present HBsAg to HBsAg-specific, DR0301-restricted T cell lines. Non-fractionated peripheral blood mononuclear cells (PBMC) from the DR0301(+) NR did not proliferate to HBsAg in vitro, whereas they proliferated vigorously upon stimulation with tetanus toxoid, thus ruling out the presence of a generalized immunodeficiency. We therefore conclude that HLA-DR0301(+) NR vaccinees are not deficient in their HBsAg-presentation. Because it was demonstrated that recently activated T cells can apparently bypass the requirement for B7, we may have overlooked the role of the B7-co-stimulation in our set-up that used HBsAg-specific T cell lines. Therefore we examined the expression of B7 co-stimulatory molecules on NR-APC. CD86 was normally present on these cells and was not down-regulated after culturing the PBMC in the presence of HBsAg. We conclude that CD86 expression on CD14(+) monocytes of DR0301- and DR07-homozygous poor responders is not deficient and cannot be the mechanism underlying the non-responsiveness of these subjects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigen Presentation / immunology*
  • Antigen-Presenting Cells / immunology
  • Antigens, CD / immunology*
  • B7-1 Antigen / immunology
  • B7-2 Antigen
  • Cell Line
  • Coculture Techniques / methods
  • HLA-DP Antigens / immunology
  • HLA-DP beta-Chains
  • HLA-DR Antigens / immunology
  • HLA-DR3 Antigen
  • Hepatitis B Surface Antigens / immunology*
  • Hepatitis B Vaccines / immunology*
  • Humans
  • Immunity, Cellular / immunology
  • Leukocyte Count
  • Leukocytes, Mononuclear / immunology
  • Lipopolysaccharide Receptors / immunology
  • Membrane Glycoproteins / immunology
  • T-Lymphocytes / immunology

Substances

  • Antigens, CD
  • B7-1 Antigen
  • B7-2 Antigen
  • CD86 protein, human
  • HLA-DP Antigens
  • HLA-DP beta-Chains
  • HLA-DPB1*02:01 antigen
  • HLA-DR Antigens
  • HLA-DR0301 antigen
  • HLA-DR3 Antigen
  • Hepatitis B Surface Antigens
  • Hepatitis B Vaccines
  • Lipopolysaccharide Receptors
  • Membrane Glycoproteins